Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves

Journal of the National Cancer Institute

Volumn 102, Issue 2, 2010, Pages 107-118

  Gil, Ziv ^a,b   Cavel, Oren ^a   Kelly, Kaitlyn ^b   Brader, Peter ^b,c   Rein, Avigail ^a,b   Gao, Sizhi P ^b   Carlson, Diane L ^b   Shah, Jatin P ^b   Fong, Yuman ^b   Wong, Richard J ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN RET; PROTEIN TYROSINE KINASE INHIBITOR; PYRAZOLOPYRIMIDINE 1; PYRAZOLOPYRIMIDINE DERIVATIVE; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MALE; MOUSE; NERVE FIBER; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PARACRINE SIGNALING; PARALYSIS; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; SCIATIC NERVE; SPINAL GANGLION;

EID: 75149195316     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp456     Document Type: Article

References (40)

1. Nakao A, Harada A, Nonami T, Kaneko T, Takagi H. Clinical signifi-cance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas. 1996; 12 (4): 357-361.
2. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009; 115 (15): 3379-3391.
3. Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci. 2002; 3 (5): 383-394.
4. Durbec P, Marcos-Gutierrez CV, Kilkenny C, et al. GDNF signalling through the Ret receptor tyrosine kinase. Nature. 1996; 381 (6585): 789-793.
5. Tang MJ, Worley D, Sanicola M, Dressler GR. The RET-glial cell-derived neurotrophic factor (GDNF) pathway stimulates migration and chemoattraction of epithelial cells. J Cell Biol. 1998; 142 (5): 1337-1345.
6. Pozas E, Ibanez CF. GDNF and GFRalpha1 promote differentiation and tangential migration of cortical GABAergic neurons. Neuron. 2005; 45 (5): 701-713.
7. Pichel JG, Shen L, Sheng HZ, et al. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature. 1996; 382 (6586): 73-76.
8. Manie S, Santoro M, Fusco A, Billaud M. The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet. 2001; 17 (10): 580-589.
9. Sawai H, Okada Y, Kazanjian K, et al. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling. Cancer Res. 2005; 65 (24): 11536-11544.
10. Veit C, Genze F, Menke A, et al. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Cancer Res. 2004; 64 (15): 5291-5300.
11. Walsh GS, Orike N, Kaplan DR, Miller FD. The invulnerability of adult neurons: a critical role for p73. J Neurosci. 2004; 24 (43): 9638-9647.
12. Ayala GE, Wheeler TM, Shine HD, et al. In vitro dorsal root ganglia and human prostate cell line interaction: redefi ning perineural invasion in prostate cancer. Prostate. 2001; 49 (3): 213-223.
13. Rubinson DA, Dillon CP, Kwiatkowski AV, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 2003; 33 (3): 401-406.
14. Hu D, Hu R, Berde CB. Neurologic evaluation of infant and adult rats before and after sciatic nerve blockade. Anesthesiology. 1997; 86 (4): 957-965.
15. Mashour GA, Moulding HD, Chahlavi A, et al. Therapeutic effi cacy of G207 in a novel peripheral nerve sheath tumor model. Exp Neurol. 2001; 169 (1): 64-71.
16. Okada Y, Takeyama H, Sato M, et al. Experimental implication of celiac ganglionotropic invasion of pancreatic-cancer cells bearing c-ret proto-oncogene with reference to glial-cell-line-derived neurotrophic factor (GDNF). Int J Cancer. 1999; 81 (1): 67-73.
17. van Weering DH, Bos JL. Glial cell line-derived neurotrophic factor induces Ret-mediated lamellipodia formation. J Biol Chem. 1997; 272 (1): 249-254.
18. Esseghir S, Todd SK, Hunt T, et al. A role for glial cell derived neurotrophic factor induced expression by infl ammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer. Cancer Res. 2007; 67 (24): 11732-11741.
19. Esseghir S, Reis-Filho JS, Kennedy A, et al. Identifi cation of transmem-brane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. J Pathol. 2006; 210 (4): 420-430.
20. Garnis C, Davies JJ, Buys TP, et al. Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression. Oncogene. 2005; 24 (30): 4806-4812.
21. Iwahashi N, Nagasaka T, Tezel G, et al. Expression of glial cell line-derived neurotrophic factor correlates with perineural invasion of bile duct carcinoma. Cancer. 2002; 94 (1): 167-174.
22. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 1993; 260 (5111): 1130-1132.
23. Grimm L, Holinski-Feder E, Teodoridis J, et al. Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 3 ′-UTR and alternative splice products. Hum Mol Genet. 1998; 7 (12): 1873-1886.
24. Funahashi H, Takeyama H, Sawai H, et al. Alteration of integrin expression by glial cell line-derived neurotrophic factor (GDNF) in human pancreatic cancer cells. Pancreas. 2003; 27 (2): 190-196.
25. Funahashi H, Okada Y, Sawai H, et al. The role of glial cell line-derived neurotrophic factor (GDNF) and integrins for invasion and metastasis in human pancreatic cancer cells. J Surg Oncol. 2005; 91 (1): 77-83.
26. Song H, Moon A. Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways. Neurosci Res. 2006; 56 (1): 29-38.
27. Cullen-McEwen LA, Drago J, Bertram JF. Nephron endowment in glial cell line-derived neurotrophic factor (GDNF) heterozygous mice. Kidney Int. 2001; 60 (1): 31-36.
28. Carlomagno F, Vitagliano D, Guida T, et al. The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes. Cancer Res. 2002; 62 (4): 1077-1082.
29. Carniti C, Perego C, Mondellini P, Pierotti MA, Bongarzone I. PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncopro-teins through proteosomal targeting. Cancer Res. 2003; 63 (9): 2234-2243.
30. Gil Z, Rein A, Brader P, et al. Nerve-sparing therapy with oncolytic herpes virus for cancers with neural invasion. Clin Cancer Res. 2007; 13 (21): 6479-6485.
31. Batchelor PE, Liberatore GT, Wong JY, et al. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neu-rotrophic factor. J Neurosci. 1999; 19 (5): 1708-1716.
32. Fukuda T, Kiuchi K, Takahashi M. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. J Biol Chem. 2002; 277 (21): 19114-19121.
33. You L, Ebner S, Kruse FE. Glial cell-derived neurotrophic factor (GDNF)-induced migration and signal transduction in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2001; 42 (11): 2496-2504.
34. Trupp M, Scott R, Whittemore SR, Ibanez CF. Ret-dependent and-independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J Biol Chem. 1999; 274 (30): 20885-20894.
35. Sariola H, Saarma M. Novel functions and signalling pathways for GDNF. J Cell Sci. 2003; 116 (pt 19): 3855-3862.
36. Ito Y, Okada Y, Sato M, et al. Expression of glial cell line-derived neu-rotrophic factor family members and their receptors in pancreatic cancers. Surgery. 2005; 138 (4): 788-794.
37. Dawson DM, Lawrence EG, MacLennan GT, et al. Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer. J Natl Cancer Inst. 1998; 90 (7): 519-523.
38. Hanke JH, Gardner JP, Dow RL, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck-and FynT-dependent T cell activation. J Biol Chem. 1996; 271 (2): 695-701.
39. Melillo RM, Barone MV, Lupoli G, et al. Ret-mediated mitogenesis requires Src kinase activity. Cancer Res. 1999; 59 (5): 1120-1126.
40. Croyle M, Akeno N, Knauf JA, et al. RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR. Cancer Res. 2008; 68 (11): 4183-4191.